| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75692a38a2eff0ee47b923b5ecb6bc79 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 |
| filingDate |
1974-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1976-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2775e72c1342bd6f9264ffeeb89e518a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf8e303832af24d843f489c8a39ba8fe |
| publicationDate |
1976-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3968215-A |
| titleOfInvention |
Drug having an anti-agglutinating effect on platelets and hypocoagulating effect |
| abstract |
A drug having an anti-agglutinating effect on platelets and a hypocoagulating effect formed of an association of papaverine or a physiologically acceptable salt thereof with a thiosulphate of a physiologically acceptable metal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009175783-A1 |
| priorityDate |
1973-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |